Onconetix Stockholders Approve Reverse Stock Split Proposal

Onconetix ( (ONCO) ) has provided an update.

On May 30, 2025, Onconetix, Inc. held a special meeting of stockholders where two key proposals were approved. The first was an amendment to the company’s Certificate of Incorporation to allow a reverse stock split at a ratio between 1-for-10 and 1-for-150, to be determined by the Board. The second was the approval to adjourn the meeting if necessary to gather more proxies for the reverse stock split proposal. Both proposals received sufficient votes for approval.

Spark’s Take on ONCO Stock

According to Spark, TipRanks’ AI Analyst, ONCO is a Underperform.

Onconetix’s overall score reflects substantial financial difficulties with significant operating losses and negative profitability metrics. The technical analysis suggests a bearish trend, and the valuation metrics are unfavorable due to negative earnings. These factors combine to give the stock a low attractiveness score.

To see Spark’s full report on ONCO stock, click here.

More about Onconetix

Average Trading Volume: 22,303,012

Technical Sentiment Signal: Sell

Current Market Cap: $3.37M

For detailed information about ONCO stock, go to TipRanks’ Stock Analysis page.